PerkinElmer Q3 Receipts Grow 7 Percent But Profits Sink 7 Percent; Shares Up 5.7 Percent | GenomeWeb
NEW YORK (GenomeWeb News) — PerkinElmer today said revenue for the third quarter increased 7 percent while profits fell 7 percent.
 
Total receipts for the three months ended Sept. 30 increased to $387 million from $360 million year over year.
 
Revenue from its life and analytical sciences division grew to $284 million from $259 million year over year.
 
The company spent $24.8 million on research and development in the quarter, up $3 million from last year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.